Dupixent (Dupilumab): Uses, Dosage, and Side Effects

What Is Dupixent (Dupilumab)?

Dupixent (dupilumab) is a prescription biologic medication used to treat several inflammatory conditions, including atopic dermatitis, asthma, and chronic rhinosinusitis with nasal polyps. This injectable medication works by targeting specific proteins in the immune system that contribute to inflammation and allergic responses in the body.

How Dupixent Differs From Other Treatments

Unlike traditional treatments that broadly suppress the immune system, Dupixent specifically blocks two key proteins called interleukin-4 (IL-4) and interleukin-13 (IL-13). These proteins play a central role in type 2 inflammation. This targeted approach makes Dupixent part of a newer class of allergy medicines designed to address underlying disease mechanisms.

Administration and Availability

Dupixent is administered as a subcutaneous injection, typically every two weeks. Patients can self-inject at home after proper training from a healthcare provider. The medication comes in pre-filled syringes or pens, making home administration more convenient for those managing chronic conditions.

How Does Dupixent Work?

Dupixent works by blocking two key proteins in the immune system called interleukin-4 (IL-4) and interleukin-13 (IL-13), which drive type 2 inflammation. By inhibiting these specific signaling pathways, the medication reduces the inflammatory responses responsible for conditions like atopic dermatitis, asthma, and chronic rhinosinusitis with nasal polyps.

Targeting Type 2 Inflammation

Type 2 inflammation occurs when the immune system overreacts to certain triggers, producing excessive amounts of IL-4 and IL-13. These proteins cause symptoms like skin rashes, airway constriction, and nasal polyp growth. Unlike biologics for asthma that target other pathways, Dupixent specifically addresses this inflammatory cascade at its source.

Differences From Other Biologic Treatments

While other biologics like omalizumab target immunoglobulin E (IgE), Dupixent focuses on interleukins. This distinction makes it effective for patients who may not respond to IgE-targeted therapies. The medication's dual-blocking mechanism provides broader coverage against type 2 inflammatory conditions, offering relief for multiple symptoms simultaneously.

What Conditions Is Dupixent (Dupilumab) Approved to Treat?

Dupixent is FDA-approved to treat five conditions driven by type 2 inflammation: atopic dermatitis, asthma, chronic rhinosinusitis with nasal polyps, eosinophilic esophagitis, and prurigo nodularis. Each condition involves overactive immune responses that Dupixent targets by blocking IL-4 and IL-13 signaling pathways, providing relief when other treatments fail.

Atopic Dermatitis

Dupixent treats moderate-to-severe atopic dermatitis in adults and children aged 6 months and older. Patients who haven't responded adequately to topical therapies may benefit from this biologic. Clinical trials show significant improvements in skin clearance and itch reduction within weeks of starting treatment.

Asthma

For moderate-to-severe asthma with an eosinophilic phenotype or oral corticosteroid-dependent asthma, Dupixent serves as an add-on maintenance treatment. It's approved for patients aged 6 years and older. The medication reduces asthma exacerbations and may decrease the need for oral corticosteroids in many patients.

Chronic Rhinosinusitis with Nasal Polyps

Adults with inadequately controlled chronic rhinosinusitis with nasal polyps can use Dupixent as an add-on maintenance therapy. The medication shrinks nasal polyps and improves symptoms like nasal congestion and loss of smell. Many patients experience significant relief when other treatments haven't provided adequate control.

Eosinophilic Esophagitis

Dupixent is approved for eosinophilic esophagitis in adults and children aged 1 year and older weighing at least 15 kg. This condition causes inflammation and difficulty swallowing. The medication reduces esophageal inflammation and improves swallowing function in affected patients.

Prurigo Nodularis

Adults with prurigo nodularis, a chronic skin condition causing intensely itchy nodules, may benefit from Dupixent treatment. The medication addresses the underlying type 2 inflammation responsible for this debilitating condition. Patients often experience reduced itching and improved skin appearance with continued use.

What Should Patients Know Before Using Dupixent?

Patients should know that Dupixent requires careful consideration of their medical history and current health status before starting treatment. Discussing all existing conditions, medications, and allergies with a healthcare provider is essential. This biologic medication works differently than traditional treatments like antihistamines or allergy shots, so proper screening ensures safe and effective use.

Before beginning Dupixent, patients must inform their doctor about any scheduled vaccinations, as live vaccines should be avoided during treatment. Those with parasitic infections should have them treated before starting the medication. Pregnant or breastfeeding individuals should discuss potential risks with their healthcare provider, as limited data exists regarding Dupixent's effects during pregnancy.

Who Should Not Take Dupilumab

Certain individuals should avoid Dupixent entirely due to safety concerns:

• People with a known hypersensitivity to dupilumab or any inactive ingredients in the formulation • Patients who have experienced severe allergic reactions to previous Dupixent injections • Individuals with untreated parasitic infections

Patients with pre-existing eye conditions should exercise caution, as Dupixent may worsen certain eye problems. Those currently using oral corticosteroids should not abruptly stop their medication when starting Dupixent without medical guidance. A gradual tapering approach under physician supervision is typically recommended for these patients.

What Is the Proper Dosing and Administration of Dupixent?

The proper dosing of Dupixent varies based on the condition being treated, patient age, and body weight. Dupixent is administered as a subcutaneous injection, typically given every two weeks after an initial loading dose. Healthcare providers determine the specific dosing schedule based on individual patient factors and the approved indication.

Administration Method

Dupixent comes in pre-filled syringes or auto-injectors for subcutaneous injection. Patients can self-administer at home after receiving proper training from their healthcare provider. Common injection sites include:

• The thigh • The abdomen (avoiding the navel area) • The upper arm (when administered by a caregiver)

Dosing by Condition

Dosing schedules differ depending on the treated condition. For adults with atopic dermatitis, the typical regimen starts with a 600 mg loading dose followed by 300 mg every two weeks. Asthma patients may receive different doses based on whether they have oral corticosteroid-dependent asthma. Unlike allergen-specific immunotherapy, which gradually builds tolerance, Dupixent works by blocking specific inflammatory pathways immediately upon administration.

What Are the Potential Side Effects of Dupixent?

The potential side effects of Dupixent range from mild injection site reactions to more serious allergic responses. Most patients tolerate the medication well, but understanding possible adverse effects helps ensure safe treatment. Patients should discuss any concerns with their healthcare provider before starting therapy.

Common Side Effects

Injection site reactions are the most frequently reported side effect of Dupixent. These typically include redness, swelling, and itching at the injection location. Other common side effects include:

• Cold sores or herpes simplex virus infections • Eye and eyelid inflammation, including conjunctivitis • Upper respiratory infections • Headaches • Joint pain

Most common side effects are mild to moderate and tend to decrease over time as the body adjusts to the medication.

Serious Side Effects

While rare, serious side effects require immediate medical attention. Allergic reactions can occur, including symptoms like difficulty breathing, swelling of the face or throat, and hives. For severe allergic reactions, patients may need emergency treatment such as Neffy nasal spray or epinephrine. Eye problems, including keratitis, may develop in some patients. Contact your healthcare provider immediately if you experience vision changes, eye pain, or worsening eye symptoms during treatment.

What Safety Information Should Patients Know About Dupixent?

Patients should know that Dupixent requires careful monitoring and open communication with their healthcare provider throughout treatment. Key safety considerations include potential drug interactions, proper storage requirements, and the importance of reporting any new or worsening symptoms promptly to ensure the medication remains safe and effective.

Drug Interactions and Precautions

Before starting Dupixent, inform your doctor about all medications you currently take, including prescription drugs, over-the-counter (OTC) medications, and supplements. Live vaccines should be avoided during treatment. Patients using corticosteroids should not stop them abruptly without medical guidance, as gradual tapering may be necessary.

Storage and Handling

Proper storage ensures Dupixent maintains its effectiveness. Keep the medication refrigerated between 36°F to 46°F and protect it from light. Never freeze Dupixent or use it if it has been frozen. Before injection, allow the medication to reach room temperature naturally. Patients exploring other allergy treatment without injections may find sublingual immunotherapy a convenient alternative worth discussing with their allergist.

Live Allergy-Free with Wyndly

If you want long-term relief from your allergies, Wyndly can help. Our doctors will help you identify your allergy triggers and create a personalized treatment plan to get you the lifelong relief you deserve. Start by taking our quick online allergy assessment today!

Frequently Asked Questions

What is the monthly cost of Dupixent?

Dupixent costs approximately $3,500 to $4,000 per month without insurance. With insurance coverage, out-of-pocket costs vary significantly based on your plan. The manufacturer offers a copay assistance program that may reduce costs to as little as $0 for eligible commercially insured patients.

What does Dupixent do to your body?

Dupixent blocks two proteins called interleukin-4 and interleukin-13 that cause inflammation in conditions like eczema, asthma, and chronic sinusitis. By targeting these specific immune pathways, Dupixent reduces allergic inflammation at its source rather than suppressing the entire immune system like some other treatments.

What is the dupilumab controversy?

The dupilumab controversy centers on its high cost, making it inaccessible for many patients. Additionally, some studies have raised concerns about potential side effects, including conjunctivitis and injection site reactions. There are also debates about its long-term effectiveness compared to traditional allergy immunotherapy treatments.

Are dupilumab and Dupixent the same thing?

Yes, dupilumab and Dupixent are the same thing. Dupilumab is the generic drug name, while Dupixent is the brand name under which it's marketed. This injectable biologic medication treats conditions like moderate-to-severe eczema, asthma, chronic rhinosinusitis with nasal polyps, and eosinophilic esophagitis.

Why do insurance companies deny Dupixent?

Insurance companies deny Dupixent coverage for several reasons: high cost (approximately $36,000 annually), failure to try cheaper alternatives first, not meeting specific diagnostic criteria, incomplete documentation from physicians, or the condition being treated falls outside approved indications. Prior authorization requirements and step therapy protocols are common barriers.

What is the most common side effect of Dupixent?

The most common side effect of Dupixent is injection site reactions, including redness, swelling, itching, and pain where the medication was administered. Other frequently reported side effects include eye problems like conjunctivitis, cold sores on the lips or mouth, and headaches. Most side effects are mild to moderate.

Can I stop Dupixent cold turkey?

You should not stop Dupixent cold turkey without consulting your doctor. Abruptly discontinuing this medication may cause your allergy or eczema symptoms to return or worsen. Your healthcare provider can create a safe tapering plan or recommend alternative treatments to manage your condition effectively.

What are the worst side effects of Dupixent?

The worst side effects of Dupixent include serious allergic reactions, eye problems like conjunctivitis and keratitis, joint pain, and injection site reactions. Some patients report cold sores or herpes simplex infections. Rarely, eosinophilia or parasitic infections may occur. Always discuss potential risks with your healthcare provider before starting treatment.

What is Dupixent prescribed for?

Dupixent is prescribed for moderate-to-severe atopic dermatitis (eczema), moderate-to-severe asthma, chronic rhinosinusitis with nasal polyps, eosinophilic esophagitis, and prurigo nodularis. It works by blocking specific proteins that cause inflammation. Dupixent is typically used when other treatments haven't provided adequate symptom control.